Inogen (INGN) Minority Interest (2012 - 2013)
Inogen (INGN) reported Minority Interest of $118.7 million for Q4 2013, up 8.53% year-over-year from $109.3 million in Q4 2012, and up 5.98% on a QoQ basis from $112.0 million in Q1 2013.
Inogen (INGN) has 2 years of Minority Interest data on file, last reported at $118.7 million in Q4 2013.
- Quarterly Minority Interest rose 8.53% year-over-year to $118.7 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $118.7 million (up 8.53% YoY) and the FY2013 annual result came in at $118.7 million, up 8.53% from the prior year.
- Minority Interest climbed to $118.7 million in Q4 2013 per INGN's latest filing, from $112.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $118.7 million in Q4 2013 and bottomed at $109.3 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 118.67 Mn |
| Mar 31, 2013 | 111.98 Mn |
| Dec 31, 2012 | 109.35 Mn |